Experiment: 2K8F

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0 mM [U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
2	2D 1H-1H NOESY	1.0 mM TAZ2, 1.1 mM TAD(1-39)	100% D2O	200	6.3	ambient	308
3	3D CBCA(CO)NH	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
4	3D HNCACB	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
5	3D HNCO	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
6	3D HN(CA)CO	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
7	3D HNCA	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
8	3D H(CCO)NH	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
9	3D HCCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
10	3D HNHA	1.0 mM [U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
11	3D 1H-15N NOESY	1.0 mM [U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
12	3D 1H-13C NOESY	1.0 mM [U-100% 13C; U-100% 15N] TAZ2, 1.1 mM TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
13	2D 1H-15N HSQC	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
14	3D CBCA(CO)NH	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
15	3D HNCACB	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
16	3D HNCA	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
17	3D HNCO	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
18	3D HN(CA)CO	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
19	3D H(CCO)NH	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
20	3D HCCH-TOCSY	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
21	3D 1H-15N NOESY	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308
22	3D 1H-13C NOESY	1.1 mM TAZ2, 1.0 mM [U-100% 15N] TAD(1-39), 1.0 mM [U-100% 13C; U-100% 15N] TAD(1-39)	90% H2O/10% D2O	200	6.3	ambient	308

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	DRX	700

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing, molecular dynamics, torsion angle dynamics		NMRDraw

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	50
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Additional NMR Experimental Information
Details	All the data related to chemical shift assignments were collected by 500 MHz, and 3D NOESY data were recorded by 700 MHz.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	data analysis	NMRPipe	updated	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	NMRView	updated	Johnson, One Moon Scientific
4	structure solution	X-PLOR NIH	2.19	Schwieters, Kuszewski, Tjandra and Clore
5	refinement	X-PLOR NIH	2.19	Schwieters, Kuszewski, Tjandra and Clore
6	structure solution	TALOS	updated	Cornilescu, Delaglio and Bax
7	structure validation	ProcheckNMR	updated	Laskowski and MacArthur
8	structure validation	MolProbity	3.15	Richardson
9	figure preparation	Insight II	updated	Accelrys Software Inc.
10	structure solution	SYBYL	8.0	Tripos

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

2K8F

Structural Basis for the Regulation of p53 Function by p300